Antibodies Produced by CLL Phenotype B Cells in Patients With Myasthenia Gravis Are Not Directed Against Neuromuscular Endplates.
Neurology(R) neuroimmunology & neuroinflammation（2023）
摘要
This is a single case study and provides Class IV evidence that obinutuzumab is safe to use in patients with MG.
更多查看译文
关键词
myasthenia gravis,antibodies
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要